Merck's 9.16 Billion Trading Volume Ranks 77th as Company Expands and Announces Clinical Trial

On May 22, 2025, Merck's trading volume reached 9.16 billion, ranking 77th in the day's stock market. Merck (MRK) rose 1.12%.

Merck has announced that it will be conducting a clinical trial for its new drug, which is designed to treat a rare form of cancer. The trial will involve 500 patients and is expected to last for two years. The company has stated that the results of the trial will be crucial in determining the drug's efficacy and safety.

Merck has also announced that it will be expanding its manufacturing capabilities in order to meet the growing demand for its products. The company has stated that it will be investing $500 million in new facilities and equipment, which will create 1,000 new jobs.

Merck has also announced that it will be acquiring a biotechnology company, which specializes in the development of gene therapies. The acquisition is expected to be completed by the end of the year and will allow Merck to expand its portfolio of innovative treatments.